Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kala-azar patients in Delhi

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 1, 2000, Pages 3-6

  Singh, Sarman ^a   Dwivedi, S N ^a   Sood, Rita ^a   Wali, J P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PENTAMIDINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL HYGIENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INJECTION; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE; NEPAL; SEROPREVALENCE;

EID: 0033957243     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540050164137     Document Type: Article

References (18)

1. Sanyal RK. Leishmaniasis in Indian subcontinent. In: Chang K P, Bray R S, eds. Leishmaniasis. Oxford: Elsevier Science Publishers. 1985: 443-67.
2. WHO. Control of leishmaniasis. Report of a WHO expert committee. Geneva: WHO Technical Report Series. 1990: 793.
3. Thakur CP, Kumar M, Pandey AK. Comparison of regimens of treatment of antimony-resistant kala-uzar patients. Am J Trop Med Hyg 1991; 45: 535-41.
4. Singh S, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community based study. Int J Infect Dis (In press).
5. Piot P. Andre FE, eds. Hepatitis B: a sexually transmitted disease in heterosexuals. Amsterdam: Elsevier Science Publishers BV, 1990: 104.
6. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997: 26 Suppl 1: 15-20s.
7. Wig N, Handa R. Aggarwal P, Biswas A, Singh S, Wali JP. Kala-azar in AIDS. J Assoc Phys India 1997; 45: 582.
8. Singh S. AIDS care in India. The AIDS Reader 1997; 7: 100-6.
9. Druce JD, Locarnini SA, Birch CJ. Syringe cleaning techniques and transmission of HIV. AIDS 1995; 9: 1105-7.
10. Hayashi J, Hishihara Y, Yamaji K, Yushimura E, Kawakami Y, Akazawa K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995; 90: 794-9.
11. El-Sayed NM, Gomatos PJ, Rodior GR, Weirzba TF, Darwish A. Khasawa S, et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus. human immunodeficiency virus and Treponema pallidum infection: association of hepatitis C virus infection with specific regions of Egypt. Am J Trop Med Hyg 1996; 55: 179-84.
12. Guadagnino V, Straffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotypic distribution of hepatitis C virus infection in the general population: a community based survey in Southern Italy. Hepatology 1997; 26: 1006-11.
13. Singh YN, Bhargava M, Malaviya AN, Tripathy SP. HIV infection in Asian Indian patients with hemophilia and those who had multiple transfusions. Indian J Med Res 1991; 93: 12-4.
14. Jaiswal SPB, Chitnis DS, Naik G, Artwani KK, Pandit CS. Sepaha A. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996; 104: 177-81.
15. Cribier B, Rey D, Schmitt C, Lang JM, Kim A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 1995; 9: 1131-6.
16. Abe K, Inchauspe G. Transmission of hepatitis C by saliva. Lancet 1991: 337: 248.
17. Kiyosawa K, Sodeyama T. Tanaka E, et al. Intrafamilial transmission of hepatitis C virus in Japan. J Med Virol 1991; 33: 114-6.
18. Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Robero ML, Alberti A. Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis. Lancet 1989; ii: 1162.